Precision Hepatobiliary Surgery for Liver Cancer and Liver Disease in Shanghai
Surgical resection remains the gold standard curative treatment for early and intermediate hepatocellular carcinoma (HCC) in patients with adequate liver function reserve. The challenge lies in removing the tumor completely while preserving sufficient healthy liver tissue to prevent post-operative liver failure — a balance that requires both technical mastery and precise pre-operative planning. At Shanghai First People's Hospital, Dr. Hang Hualian leads the hepatobiliary surgery department with expertise in precision liver resection and liver transplantation across the full spectrum of hepatobiliary diseases.
Featured Specialist: Dr. Hang Hualian (杭化莲)
Dr. Hang Hualian is Director of the Department of Hepatobiliary Surgery at Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine (Shanghai Jiaotong Daxue Yixueyuan Fushu Di Yi Renmin Yiyuan) — one of Shanghai's major academic medical centers with a long history of hepatobiliary surgical excellence.
Dr. Hang's surgical expertise encompasses:
- Precision liver resection for liver cancer and all hepatobiliary diseases — using advanced anatomical and image-guided techniques to achieve complete tumor removal with maximum liver tissue preservation
- Liver transplantation — proficiency across all types of liver transplant surgery, including deceased donor and living donor procedures
Precision Liver Resection: The Modern Standard
"Precision liver resection" (精准肖切除) is not simply a marketing term — it represents a specific surgical philosophy and technical framework that has transformed hepatic surgery outcomes over the past two decades. Dr. Hang's precision resection approach integrates:
Pre-operative Planning
- 3D liver volumetry: CT or MRI-based three-dimensional reconstruction of the liver to calculate the future liver remnant (FLR) volume and ensure adequate post-operative liver function
- Virtual hepatectomy simulation: Computer-assisted planning of the resection plane to achieve R0 margins while maximizing FLR
- Indocyanine green (ICG) clearance testing: Functional assessment of liver reserve to determine safe resection limits
- Portal vein embolization (PVE): Pre-operative embolization of the portal vein branch supplying the tumor-bearing liver to induce hypertrophy of the future remnant — enabling resection in patients who would otherwise have insufficient liver reserve
Intraoperative Techniques
- Anatomical resection: Removal of the tumor along anatomical boundaries (segments, sections, lobes) rather than simple wedge excision — reduces intrahepatic recurrence by removing the portal territory at risk for micrometastatic spread
- Intraoperative ultrasound: Real-time imaging to identify tumor margins, satellite nodules, and vascular relationships during surgery
- ICG fluorescence imaging: Intraoperative fluorescence guidance to visualize tumor margins and bile leaks in real time
- Laparoscopic and robotic-assisted hepatectomy: Minimally invasive approaches for appropriate tumors, reducing blood loss, hospital stay, and recovery time
- Pringle maneuver and selective vascular control: Techniques to minimize intraoperative blood loss during parenchymal transection
- Ultrasonic dissector (CUSA) and bipolar coagulation: Precision parenchymal transection tools that minimize blood loss and bile duct injury
Post-operative Management
- Enhanced recovery after surgery (ERAS) protocols to minimize hospital stay and complications
- Monitoring for post-hepatectomy liver failure, bile leak, and hemorrhage
- Coordination with medical oncology for adjuvant systemic therapy planning
Liver Transplantation
For patients with HCC who are not candidates for resection due to underlying cirrhosis or insufficient liver reserve, liver transplantation offers the dual benefit of removing the cancer and replacing the diseased liver. Dr. Hang's transplant expertise includes:
- Deceased donor liver transplantation (DDLT): Standard whole-liver transplant from a brain-dead or cardiac-death donor
- Living donor liver transplantation (LDLT): Using a portion of a living donor's liver — right lobe or left lobe — when a deceased donor organ is not available in time
- HCC transplant eligibility assessment: Evaluation against Milan Criteria and expanded criteria (UCSF, Hangzhou) to determine transplant candidacy
- Bridging therapy coordination: Working with interventional oncology for TACE or ablation to control tumor growth while awaiting transplantation
- Post-transplant management: Immunosuppression optimization and HCC recurrence surveillance
Hepatobiliary Diseases Treated
Beyond liver cancer, Dr. Hang's precision hepatobiliary surgery program addresses the full spectrum of liver and biliary diseases:
- Hepatocellular carcinoma (HCC): Primary liver cancer — resection or transplantation
- Intrahepatic cholangiocarcinoma: Primary bile duct cancer within the liver
- Colorectal liver metastases: Surgical resection for selected patients with liver-only or liver-dominant metastatic colorectal cancer
- Hepatic hemangioma: Large or symptomatic benign liver tumors requiring resection
- Liver cysts and echinococcosis: Surgical management of complex cystic liver disease
- Gallbladder cancer: Radical cholecystectomy with liver resection and lymph node dissection
- Bile duct stones and strictures: Complex biliary reconstruction surgery
- Benign liver tumors: Focal nodular hyperplasia, hepatocellular adenoma
How CMCS Coordinates Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading hepatobiliary surgeons, including Dr. Hang Hualian at Shanghai First People's Hospital, and manage every step of the process:
- Review of existing liver imaging (MRI with hepatobiliary contrast, CT, ultrasound), tumor markers (AFP, CA19-9), liver function tests, and viral hepatitis status
- Surgical resectability assessment and transplant eligibility evaluation with Dr. Hang's team
- Coordination with interventional oncology for pre-operative bridging therapy or portal vein embolization
- Coordination with medical oncology for neoadjuvant or adjuvant systemic therapy
- Appointment scheduling with priority access
- Medical interpretation during consultations and surgical planning discussions
- Logistics support: accommodation near Shanghai First People's Hospital, visa assistance, and local transport
- Post-operative follow-up and remote monitoring coordination
Get in Touch
If you have liver cancer or another hepatobiliary condition requiring surgical evaluation in Shanghai, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commenti